多图谱方法用于活性骨髓保护放疗:在NRG-GY006试验中的实现
研究基于144例训练集构建多图谱活性骨髓(ABM)分割方法,并在NRG-GY006临床试验的32例患者中验证。图谱法与个体化PET/CT分割的ABM体积相近(Dice系数0.73),图谱法计划可降低骨盆骨髓剂量且靶区和其他正常组织剂量学无显著差异,有望在无PET/CT条件下实现ABM保护。
要点
- 多图谱ABM分割在NRG-GY006试验32例患者中验证,Dice系数0.73。
- 图谱法ABM体积略大于个体化分割(548.4 vs 535.1 cm3)。
- 图谱法计划降低骨盆骨髓剂量,靶区和其他正常组织剂量学无显著差异。
核心结论
- 基于图谱的ABM分割可降低骨盆骨髓剂量,同时靶区和其他正常组织剂量学与个体化分割计划相当。
- 该方法可能使无法获取PET/CT的机构也能实施ABM保护放疗。
研究设计与样本
- 多图谱方法在144例训练集上构建,并在NRG-GY006临床试验的32例患者中验证。
- 个体化ABM定义为配准的18F-FDG PET/CT图像上骨盆骨内摄取值高于个体平均标准化摄取值(SUV)的子体积。
- 比较图谱法与个体化ABM分割的Dice相似系数和平均一致距离,并生成ABM保护调强放疗计划。
- 采用线性回归比较两种方法的剂量体积指标和正常组织并发症概率。
主要发现
- 图谱法ABM体积(均值[标准差]548.4[88.3] cm3)略大于个体化ABM体积(535.1[93.2] cm3),Dice相似系数为0.73。
- 个体化计划中总骨盆骨髓V20和Dmean系统性更高,个体化ABM V10系统性更低(斜率分别为1.021[95%CI 1.005-1.037]、1.014[95%CI 1.006-1.022]、0.98[95%CI 0.97-0.99])。
- 图谱法与个体化计划在肠、直肠、膀胱、股骨头或靶区剂量体积指标上无显著差异。
临床怎么用
- 在缺乏PET/CT的条件下,可采用多图谱ABM分割方法生成ABM保护调强放疗计划。
- 图谱法计划可降低骨盆骨髓剂量,同时保持靶区和其他正常组织剂量学相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Sparing active bone marrow (ABM) can reduce acute hematologic toxicity in patients undergoing chemoradiotherapy for cervical cancer, but ABM segmentation based on positron emission tomography/computed tomography (PET/CT) is costly. We sought to develop an atlas-based ABM segmentation method for implementation in a prospective clinical trial. METHODS AND MATERIALS: A multiatlas was built on a training set of 144 patients and validated in 32 patients from the NRG-GY006 clinical trial. ABM for individual patients was defined as the subvolume of pelvic bone greater than the individual mean standardized uptake value on registered 18F-fluorodeoxyglucose PET/CT images. Atlas-based and custom ABM segmentations were compared using the Dice similarity coefficient and mean distance to agreement and used to generate ABM-sparing intensity modulated radiation therapy plans. Dose-volume metrics and normal tissue complication probabilities of the two approaches were compared using linear regression. RESULTS: Atlas-based ABM volumes (mean [standard deviation], 548.4 [88.3] cm3) were slightly larger than custom ABM volumes (535.1 [93.2] cm3), with a Dice similarity coefficient of 0.73. Total pelvic bone marrow V20 and Dmean were systematically higher and custom ABM V10 was systematically lower with custom-based plans (slope: 1.021 [95% confidence interval (CI), 1.005-1.037], 1.014 [95% CI, 1.006-1.022], and 0.98 [95% CI, 0.97-0.99], respectively). We found no significant differences between atlas-based and custom-based plans in bowel, rectum, bladder, femoral heads, or target dose-volume metrics. CONCLUSIONS: Atlas-based ABM segmentation can reduce pelvic bone marrow dose while achieving comparable target and other normal tissue dosimetry. This approach may allow ABM sparing in settings where PET/CT is unavailable.
引用
- Yusufaly T, Miller A, Medina-Palomo A, et al. A Multi-atlas Approach for Active Bone Marrow Sparing Radiation Therapy: Implementation in the NRG-GY006 Trial. Int J Radiat Oncol Biol Phys. 2020. PMID: 32629079. doi:10.1016/j.ijrobp.2020.06.071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。